Director, Investor Relations (Individual Giving)

ORGANIZATIONAL OVERVIEW

The END Fund is a leading collaborative philanthropic investment vehicle dedicated to controlling and eliminating neglected tropical diseases (NTDs). NTDs are parasitic and bacterial infectious diseases – including intestinal worms, river blindness, trachoma, schistosomiasis, lymphatic filariasis, and visceral leishmaniasis – that affect over 1.65 billion people globally. The END Fund’s vision is to ensure people can live healthy and prosperous lives free of the risk of NTDs and has set out to accomplish this by:

• Mobilizing and investing resources for maximum impact,
• Advocating for innovative, integrated and cost-effective NTD programs; and
• Facilitating philanthropic and private sector engagement to end these diseases.

By engaging a community of activist-philanthropists and taking a systems approach, the END Fund works in collaboration with governments, local and international NGOs, pharmaceutical companies, and academic partners on the global campaign to control and eliminate NTDs by 2030.

Since our founding in 2012, along with partners, the END Fund has provided over 1.8 billion treatments in 37 countries, performed over 143,000 life-changing surgeries, and trained 6.4 million health workers to preempt and treat NTDs. The END Fund works globally in over 25 countries, with a primary emphasis in Africa.

You can learn more about the END Fund here.

ABOUT THE END FUND’S INVESTOR RELATIONS TEAM

The Investor Relations team is the END Fund’s fundraising team, responsible for identifying, mobilizing, and nurturing meaningful and impactful partnerships to advance the END Fund’s mission to end neglected tropical diseases. Driven by the transformative power of collaborative philanthropy, the team works alongside a consortium of investors and champions to help harness and promote funding opportunities for underserved communities.

THE OPPORTUNITY

The END Fund’s strategic programming and priorities are in line with the WHO and global NTD community’s common roadmap to control or eliminate the most common NTDs. To meet its ambitious growth objectives, the END Fund is actively seeking to expand its community of visionary and engaged philanthropists, foundations, and corporations committed to treating and preventing the spread of NTDs.

The END Fund is looking for a savvy, seasoned development professional to join its fundraising team. S/he will develop and execute strategies to cultivate, solicit, and steward $100,000+ gifts from a portfolio of high-net-worth individuals and corporate prospects focused on the US individual giving, major gift market. A natural and collegial team player, the successful candidate will have a demonstrated track record of working collaboratively in individual and major gift fundraising with an eye towards executing on a robust plan. The successful candidate’s title will be Director with potential for advancement.

ESSENTIAL FUNCTIONS & CORE COMPETENCIES

• Under the supervision of the VP Investor Relations and in concert with the Board of Directors, Board Development Committee, CEO and other colleagues, help execute a fundraising and marketing plan to secure funding towards the Fund’s $500 Million revenue goal by 2030 in the US individual major gift (HNWI/UHNWI) market
• In collaboration with the VP Investor Relations, develop a strategy for target market of prospective donors, and create and execute an Annual Plan to implement the strategy
• Serve as one of the chief stewards of the END Fund brand by participating in cultivation meetings, correspondence, and events
• Oversee the preparation of strategy, briefing and debriefing materials for face-to-face meetings with major donors conducted by self, senior staff or Board leadership
• Contribute to the research, preparation, drafting, and editing of major concept notes and grant proposals
• Maintain prospect investor database and use advancement systems
• Contribute to pipeline reporting and meetings to share awareness of prospect status
• Design and execute ways to deepen donor commitment and enhanced gift giving, building on and enhancing the events and public outreach currently underway, while managing a personal portfolio of prospects
• Manage project work by staff colleagues and consultants
• Provide inputs to and review fundraising reporting by staff colleagues and consultants
• Perform other duties and responsibilities as assigned

EXPERIENCE AND EDUCATION

• Bachelor’s degree required; relevant graduate coursework a plus
• At least 7 to 10 years progressively responsible experience in not-for-profit fundraising and/or demonstrated transferable skills
• Proven track record for cultivating, soliciting, and securing 6 to 8-figure donations, and specific knowledge of private foundation grant making, corporate giving, and high-net worth cultivation strategies
• Exceptional ability to convey complex ideas in a clear, direct, and lively style (both written and verbal)
• Creative thinking to develop engagement strategies with maximum impact
• Exceptional interpersonal and communication skills, especially writing and content creation
• Confidence and poise to interact regularly with corporate executives and high-net-worth individuals using all forms of communications (e-mail, phone, videoconference and face-to face interaction)
• Familiarity with global health issues, and NTDs specifically, and/or an appetite and interest to learn
• Demonstrated cross-cultural skills
• A self-starter who enjoys working in a start-up environment
• Ability to work independently as well as a part of a collaborative team
• Ability to work in the U.S., and ability and desire to travel domestically and internationally

POSTING: Director, Investor Relations (Individual Giving)

LOCATION: New York City (headquarters), New Jersey, Connecticut, Pennsylvania

REPORTS TO: Vice President, Investor Relations

TRAVEL REQUIREMENTS: Up to 20% as needed

JOB POSTING DEADLINE: This position will close at 9am EDT on January 14, 2025

SALARY: The anticipated starting annual base salary range is USD $118,000-$122,000

OUR PHILOSOPHY AND BENEFITS

The END Fund is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. It is our policy and intent that all qualified persons be given full and equal opportunities for employment, training, promotions, wages, benefits, and all other privileges, terms, and conditions of employment.

The END Fund is at an exciting stage of organizational growth and we are rapidly expanding our global footprint in order to bring on the most talented team members to help advance our mission. Currently, we have team members in 13 countries and the majority of our team is based in the United States. We maintain physical headquarters in New York City, and other team members work from their homes across the US, Africa, UK and Europe. The END Fund offers a competitive compensation package intended to motivate employees to perform at the highest level by acquiring superior skills and competencies.

Our philosophy is shaped by the following guidelines: 1) understandable, 2) fair and defensible, 3) competitive, and 4) flexible. The END Fund differentiates pay based on the basis of role definition, scope of responsibilities, relevant team member experience and geographic location. We endeavor to compensate team members so that they can live with a sense of economic security within their geographic location. To ensure all compensation and benefits package offers are fair, defensible and competitive, the END Fund relies on external benchmarking data that is both role and country-specific.

Work Authorization Required

The END Fund does not sponsor work authorization or visas. All team members must independently have legal rights to work and live in the US. Our benefits packages are also informed by local contexts to ensure appropriateness and competitiveness within specific markets. Regardless of location, all END Fund team members receive cell phone and WiFi connectivity support, flexible work arrangements, a healthy annual professional development allowance, and more. The END Fund also offers employer-paid health for team members and a cost-share option for dependents of team members, as well as life insurance benefits and twelve weeks fully paid family care leave; specific benefit providers will vary modestly by country of residency.